Other Names for this Disease
- Patent ductus arteriosus with facial dysmorphism and abnormal fifth digits
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.
|Generic Name||Ibuprofen lysine|
The FDA has approved this product to be used in this manner.
|For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, et|
|More Information about this product||Drug Information Portal|